SEC Form 8-K Summary
Filing date: December 8, 2021. The submitted filing identifies the registrant as Tivic Health Systems, Inc., not Valion Bio, Inc.; investors should verify the company and filing association.
Business Context and Reporting Period
The report was furnished under Item 7.01, Regulation FD Disclosure, in connection with Tivic Health Systems’ participation in the Sidoti & Company LLC Virtual Micro Cap Conference on December 8, 2021. The company’s chief executive officer was scheduled to deliver an investor presentation.
The filing does not report a quarterly or annual financial reporting period and does not provide financial statements.
Financial and Operating Metrics
- Revenue, profit, cash flow, margins, debt, liquidity, and other financial metrics: the filing text does not provide clear values.
- The attached Exhibit 99.1 is described as an investor conference presentation dated December 8, 2021, but its substantive contents are not included in the supplied filing text.
Material Changes Versus Prior Period
The filing does not disclose material changes in financial or operating performance versus a prior comparable period.
Guidance, Outlook, Risks, and Unusual Items
The filing contains general forward-looking statement language warning that actual results may differ materially from projected results because of known and unknown risks, uncertainties, and other factors. It does not provide specific guidance, targets, contingencies, or unusual accounting items in the supplied text.
The information, including Exhibit 99.1, was furnished rather than filed for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings solely through general incorporation language.
Investor Verification Priorities
- Verify whether this filing pertains to Tivic Health Systems, Inc. or Valion Bio, Inc.; the filing itself names Tivic Health Systems, Inc. as registrant.
- Review Exhibit 99.1 and the company’s investor-relations website for the presentation’s financial metrics, strategy, and outlook.
- Consult the company’s periodic SEC filings for revenue, profitability, cash flow, debt, liquidity, and comparable-period information.
- Assess the specific risks and assumptions underlying any forward-looking statements in the presentation.